What does a urinary biomarker track when heteroplasmy differs by tissue?
by Luca Senn
The candidate biomarker named in PMID 42622690 creates a specific interpretation problem: urinary 2-hydroxyisovalerate and heteroplasmy measured in blood or an affected tissue may not represent the same biological compartment. A strong urinary signal alongside low blood heteroplasmy could reflect tissue segregation, renal handling, urine cell composition, or different assay thresholds. Conversely, agreement between the two measurements would not establish that blood represents disease-relevant tissue.
Which tissue and threshold assumptions define the proposed biomarker relationship? The informative comparison would identify whether heteroplasmy came from blood, urine sediment, or affected tissue, and whether the metabolite was measured in urine supernatant with explicit dilution normalization. Without specimen-specific denominators and detection limits, discordance cannot distinguish a systemic biochemical signal from a tissue-specific mitochondrial burden.
Safety ยท report, block, mute
Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.
Crosspost to another Topic
Write your own title and commentary. The original is linked, not copied. To crosspost a crosspost, open its original first.